Brief: Alivus Life Sciences Says USFDA Issues EIR With VAI Status For Ankleshwar Facility
April 3 (Reuters) - Alivus Life Sciences Ltd ALIV.NS: ALIVUS LIFE SCIENCES LTD - USFDA ISSUES EIR WITH VAI STATUS FOR ANKLESHWAR FACILITY Source text: ID:nBSEc8Tm9n Further company coverage: ALIV.NS ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Alivus Life Sciences
See all newsBrief: Alivus Life Sciences Incorporates Subsidiary Alivus Life Sciences Do Brasil Ltda In Brazil
Brief: Alivus Life Sciences To Buy 76% Stake In Iqgen-X Pharma For Approx 91.2 Million Rupees
India's Alivus rises to 15-month high as brokerages optimistic about drugmaker's annual outlook
India's Alivus Life Sciences rises after quarterly profit increase
Brief: Alivus Life Sciences Ltd March-Quarter Profit 1.63 Billion Rupees